Loading…
Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspect...
Saved in:
Published in: | BMJ (Online) 2019-10, Vol.367, p.l5894-l5894 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3 |
---|---|
cites | cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3 |
container_end_page | l5894 |
container_issue | |
container_start_page | l5894 |
container_title | BMJ (Online) |
container_volume | 367 |
creator | Becerra, Mercedes C Huang, Chuan-Chin Lecca, Leonid Bayona, Jaime Contreras, Carmen Calderon, Roger Yataco, Rosa Galea, Jerome Zhang, Zibiao Atwood, Sidney Cohen, Ted Mitnick, Carole D Farmer, Paul Murray, Megan |
description | AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754. |
doi_str_mv | 10.1136/bmj.l5894 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6812583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2309470953</sourcerecordid><originalsourceid>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</originalsourceid><addsrcrecordid>eNp1kU1rHDEMhk1paJZNDv0HhvbQHia11x_j6aEQQpMWEnJJz0b2eDZeZsZTfwT20P9ebzYUWuhJSHokpPdF6C0lF5Qy-clMu4tRqI6_QivaCtlQxdhrtCKd6BpFmTpF5yntCCEb1qpOijfolFHJO0LbFfr1EGFOk0_JGz_6vMcw93gJ2c3Zw4iHEHHvk4Pk8BLDNrpKhhmHAfexbHHNfcowZ3y3t8GAzS76MuFcjIu2jKG2Px8m0-Js9k8O2_AYYsYpl35_hk4GGJM7f4lr9OP668PVt-b2_ub71eVtY1jLcwNtaxhh1jmurGVEGKADZYYA8MGSlgg59HJg0EtFgDOz4V2dcJIrCaK3bI2-HPcuxUyut_W5CKNeop8g7nUAr__uzP5Rb8OTlopuRNVzjT68LIjhZ3Ep6yqZdeMIswsl6Q0jHW-r5Af03T_oLpQ41_eeqepKR0SlPh4pW6VJ0Q1_jqFEH3zV1Vf97Gtl3x_ZQ-n_2G9PsaUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2309959905</pqid></control><display><type>article</type><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Journals</source><creator>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</creator><creatorcontrib>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</creatorcontrib><description>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.l5894</identifier><identifier>PMID: 31649017</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Cohort analysis ; Drug resistance ; Epidemiology ; Households ; Isoniazid ; Multidrug resistance ; Mycobacterium tuberculosis ; Rifampin ; Skin tests ; Sputum ; Tuberculin ; Tuberculosis</subject><ispartof>BMJ (Online), 2019-10, Vol.367, p.l5894-l5894</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</citedby><cites>FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</cites><orcidid>0000-0003-0443-1986</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://bmj.com/content/367/bmj.l5894.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://bmj.com/content/367/bmj.l5894.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>112,113,230,314,780,784,885,3194,27924,27925,77594,77595</link.rule.ids></links><search><creatorcontrib>Becerra, Mercedes C</creatorcontrib><creatorcontrib>Huang, Chuan-Chin</creatorcontrib><creatorcontrib>Lecca, Leonid</creatorcontrib><creatorcontrib>Bayona, Jaime</creatorcontrib><creatorcontrib>Contreras, Carmen</creatorcontrib><creatorcontrib>Calderon, Roger</creatorcontrib><creatorcontrib>Yataco, Rosa</creatorcontrib><creatorcontrib>Galea, Jerome</creatorcontrib><creatorcontrib>Zhang, Zibiao</creatorcontrib><creatorcontrib>Atwood, Sidney</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Mitnick, Carole D</creatorcontrib><creatorcontrib>Farmer, Paul</creatorcontrib><creatorcontrib>Murray, Megan</creatorcontrib><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><title>BMJ (Online)</title><description>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</description><subject>Cohort analysis</subject><subject>Drug resistance</subject><subject>Epidemiology</subject><subject>Households</subject><subject>Isoniazid</subject><subject>Multidrug resistance</subject><subject>Mycobacterium tuberculosis</subject><subject>Rifampin</subject><subject>Skin tests</subject><subject>Sputum</subject><subject>Tuberculin</subject><subject>Tuberculosis</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><recordid>eNp1kU1rHDEMhk1paJZNDv0HhvbQHia11x_j6aEQQpMWEnJJz0b2eDZeZsZTfwT20P9ebzYUWuhJSHokpPdF6C0lF5Qy-clMu4tRqI6_QivaCtlQxdhrtCKd6BpFmTpF5yntCCEb1qpOijfolFHJO0LbFfr1EGFOk0_JGz_6vMcw93gJ2c3Zw4iHEHHvk4Pk8BLDNrpKhhmHAfexbHHNfcowZ3y3t8GAzS76MuFcjIu2jKG2Px8m0-Js9k8O2_AYYsYpl35_hk4GGJM7f4lr9OP668PVt-b2_ub71eVtY1jLcwNtaxhh1jmurGVEGKADZYYA8MGSlgg59HJg0EtFgDOz4V2dcJIrCaK3bI2-HPcuxUyut_W5CKNeop8g7nUAr__uzP5Rb8OTlopuRNVzjT68LIjhZ3Ep6yqZdeMIswsl6Q0jHW-r5Af03T_oLpQ41_eeqepKR0SlPh4pW6VJ0Q1_jqFEH3zV1Vf97Gtl3x_ZQ-n_2G9PsaUQ</recordid><startdate>20191024</startdate><enddate>20191024</enddate><creator>Becerra, Mercedes C</creator><creator>Huang, Chuan-Chin</creator><creator>Lecca, Leonid</creator><creator>Bayona, Jaime</creator><creator>Contreras, Carmen</creator><creator>Calderon, Roger</creator><creator>Yataco, Rosa</creator><creator>Galea, Jerome</creator><creator>Zhang, Zibiao</creator><creator>Atwood, Sidney</creator><creator>Cohen, Ted</creator><creator>Mitnick, Carole D</creator><creator>Farmer, Paul</creator><creator>Murray, Megan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group Ltd</general><scope>9YT</scope><scope>ACMMV</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0443-1986</orcidid></search><sort><creationdate>20191024</creationdate><title>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</title><author>Becerra, Mercedes C ; Huang, Chuan-Chin ; Lecca, Leonid ; Bayona, Jaime ; Contreras, Carmen ; Calderon, Roger ; Yataco, Rosa ; Galea, Jerome ; Zhang, Zibiao ; Atwood, Sidney ; Cohen, Ted ; Mitnick, Carole D ; Farmer, Paul ; Murray, Megan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cohort analysis</topic><topic>Drug resistance</topic><topic>Epidemiology</topic><topic>Households</topic><topic>Isoniazid</topic><topic>Multidrug resistance</topic><topic>Mycobacterium tuberculosis</topic><topic>Rifampin</topic><topic>Skin tests</topic><topic>Sputum</topic><topic>Tuberculin</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Becerra, Mercedes C</creatorcontrib><creatorcontrib>Huang, Chuan-Chin</creatorcontrib><creatorcontrib>Lecca, Leonid</creatorcontrib><creatorcontrib>Bayona, Jaime</creatorcontrib><creatorcontrib>Contreras, Carmen</creatorcontrib><creatorcontrib>Calderon, Roger</creatorcontrib><creatorcontrib>Yataco, Rosa</creatorcontrib><creatorcontrib>Galea, Jerome</creatorcontrib><creatorcontrib>Zhang, Zibiao</creatorcontrib><creatorcontrib>Atwood, Sidney</creatorcontrib><creatorcontrib>Cohen, Ted</creatorcontrib><creatorcontrib>Mitnick, Carole D</creatorcontrib><creatorcontrib>Farmer, Paul</creatorcontrib><creatorcontrib>Murray, Megan</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Becerra, Mercedes C</au><au>Huang, Chuan-Chin</au><au>Lecca, Leonid</au><au>Bayona, Jaime</au><au>Contreras, Carmen</au><au>Calderon, Roger</au><au>Yataco, Rosa</au><au>Galea, Jerome</au><au>Zhang, Zibiao</au><au>Atwood, Sidney</au><au>Cohen, Ted</au><au>Mitnick, Carole D</au><au>Farmer, Paul</au><au>Murray, Megan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study</atitle><jtitle>BMJ (Online)</jtitle><date>2019-10-24</date><risdate>2019</risdate><volume>367</volume><spage>l5894</spage><epage>l5894</epage><pages>l5894-l5894</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><pmid>31649017</pmid><doi>10.1136/bmj.l5894</doi><orcidid>https://orcid.org/0000-0003-0443-1986</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ (Online), 2019-10, Vol.367, p.l5894-l5894 |
issn | 0959-8138 1756-1833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6812583 |
source | JSTOR Archival Journals and Primary Sources Collection; BMJ Journals |
subjects | Cohort analysis Drug resistance Epidemiology Households Isoniazid Multidrug resistance Mycobacterium tuberculosis Rifampin Skin tests Sputum Tuberculin Tuberculosis |
title | Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A16%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transmissibility%20and%20potential%20for%20disease%20progression%20of%20drug%20resistant%20Mycobacterium%20tuberculosis:%20prospective%20cohort%20study&rft.jtitle=BMJ%20(Online)&rft.au=Becerra,%20Mercedes%20C&rft.date=2019-10-24&rft.volume=367&rft.spage=l5894&rft.epage=l5894&rft.pages=l5894-l5894&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.l5894&rft_dat=%3Cproquest_pubme%3E2309470953%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b374t-a77b303cee48cc305ba1f13b0aa4fc07056fd6f3ad680a43b2497b3e6486a5dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2309959905&rft_id=info:pmid/31649017&rfr_iscdi=true |